Back to Trades
Grant4
REPLIGEN CORP
RGEN
Total Value
$804.5K
Company Information
- Company Name
- REPLIGEN CORP
- Ticker Symbol
- RGEN
- CIK
- 0000730272
Insider Information
- Name
- KURIYEL RALF
- Role
- Insider
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Mar 23, 2026
- Transaction Date
- Mar 5, 2026
- Accession Number
- 0001193125-26-119047
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 | Common Stock | 5,284 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 | Derivative | 5,669 | $141.91 | Grant/Award | $804.5K |
Footnotes
- (F1)Mr. Kuriyel was awarded 5,284 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- (F2)One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029.